Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: DataM Intelligence | PRODUCT CODE: 1643870

Cover Image

PUBLISHER: DataM Intelligence | PRODUCT CODE: 1643870

India Nutraceuticals Market - 2025-2032

PUBLISHED:
PAGES: 209 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 3175
PDF & Excel (Multiple User License)
USD 3500
PDF & Excel (Enterprise License)
USD 6250

Add to Cart

India nutraceuticals market reached US$ 8.78 billion in 2024 and is expected to reach US$ 23.51 billion by 2032, growing at a CAGR of 13.10% from 2025 to 2032.

The demand for nutraceuticals in the India is growing, driven by the aging population. The elderly population of 153 million (aged 60 and above) in 2023 is expected to reach a staggering 347 million by 2050. The demographic shift highlights a rising need for products that support health, energy, cognitive function and overall well-being among older adults.

A key driver of this growth is the increasing prevalence of lifestyle-related diseases such as diabetes, hypertension and obesity. With over 77 million diabetes patients and 200 million people at risk of cardiovascular diseases, the demand for preventive healthcare solutions is escalating. Additionally, the growing middle-class population, which accounts for 35% of India's total population, is willing to spend on health and wellness products.

Functional foods and beverages are emerging as the fastest-growing segments due to their convenience and perceived health benefits. The dietary supplements segment, which includes vitamins, minerals and herbal extracts, dominates the market, contributing to over 60% of the total revenue. Key players like Amway, Dabur and Himalaya have been expanding their portfolios to cater to the increasing demand.

Government initiatives such as the National Nutritional Strategy and supportive regulations under FSSAI (Food Safety and Standards Authority of India) have created a conducive environment for market growth. Additionally, the rise of e-commerce platforms has enabled greater access to nutraceutical products, especially in tier-II and tier-III cities. With a growing focus on preventive healthcare and personalized nutrition, the Indian nutraceuticals market is poised for significant growth in the coming years.

In November 2024, Caregen and Akums collaborated to introduce cosmeceuticals and nutraceuticals in India. Through this partnership, unique topical and injectable cosmeceuticals, including cutting-edge skin and hair care products, medicines and specialty nutraceuticals will be introduced in India.

Dynamics

Growing Prevalence of Chronic Diseases

The increasing prevalence of chronic diseases in India continues to significantly drive the nutraceuticals market. Non-communicable diseases (NCDs) such as cardiovascular ailments, diabetes and obesity have seen a marked rise, prompting a shift towards preventive healthcare solutions, including nutraceuticals.

Recent studies indicate that NCDs account for approximately 67.6% of all deaths in India, with ischemic heart disease, chronic obstructive pulmonary disease (COPD), stroke and diabetes being the leading contributors. This rising burden has heightened health awareness among the population, leading to increased demand for dietary supplements and functional foods aimed at disease prevention and health maintenance.

Diabetes prevalence has been particularly concerning. As of 2024, India accounts for more than a quarter of the world's 828 million diabetes sufferers, making it the most affected country globally. This surge has led to a growing consumer base seeking nutraceutical products that help manage blood sugar levels and improve overall metabolic health.

Obesity is another critical factor contributing to the demand for nutraceuticals. The prevalence of obesity in India has reached epidemic proportions, with morbid obesity affecting 5% of the population. This trend has increased the consumption of weight management supplements and functional foods designed to promote weight loss and prevent obesity-related complications.

The Indian government's initiatives to combat NCDs have also played a role in promoting the nutraceuticals market. Programs such as the National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke (NPCDCS) aim to reduce the burden of these diseases through awareness campaigns and preventive strategies. These efforts have indirectly boosted the nutraceuticals sector by encouraging healthier lifestyles and preventive care.

Increasing Disposable Income and Urbanization

The convergence of increasing disposable incomes and rapid urbanization is significantly propelling the growth of India's nutraceuticals market. As individuals earn more and migrate to urban centers, their lifestyles and consumption patterns evolve, leading to a heightened demand for health-enhancing products. In the fiscal year 2023-24, India's per capita disposable income was projected to reach ₹214,000, marking an 8% increase from the previous year.

This rise in disposable income enables consumers to allocate more funds toward health and wellness products, including nutraceuticals. Additionally, the average monthly per capita expenditure (MPCE) in urban areas was estimated at ₹6,996, compared to ₹4,122 in rural regions, indicating higher spending capacity among urban dwellers.

Urbanization is progressing at a notable pace, with urban areas accounting for approximately 35% of India's total population. This shift has led to lifestyle changes characterized by increased work-related stress, sedentary habits and a preference for convenience foods, contributing to a rise in lifestyle-related health issues. Consequently, there is a growing consumer inclination toward preventive healthcare measures, including the consumption of nutraceuticals, to mitigate health risks, which is driving the market growth.

Lack of Consumer Awareness in Rural Areas

The growth of India's nutraceuticals market is significantly hindered by limited consumer awareness in rural areas. Approximately 65% of India's population resides in rural areas, where access to information about nutraceuticals is limited. This lack of awareness results in a lower adoption rate of dietary supplements and functional foods compared to urban counterparts. Additionally, the average monthly per capita expenditure (MPCE) in rural areas is significantly lower than in urban regions, indicating limited spending capacity among rural dwellers. Cultural factors and traditional dietary practices further impede the acceptance of nutraceutical products in these regions. Without targeted educational initiatives and marketing strategies to raise awareness about the benefits of nutraceuticals, the market's growth potential remains constrained.

Addressing this challenge requires concerted efforts from industry stakeholders and policymakers to enhance consumer education, improve distribution networks and make nutraceuticals more accessible and affordable to the rural populace. Such measures are essential to unlock the full potential of India's nutraceuticals market.

Segment Analysis

The India nutraceuticals market is segmented based on type, source form, application, end user.

In the type segment, dietary supplements are anticipated to be the fastest-growing and most dominant segment in the market

The demand for dietary supplements in India's nutraceutical market has been steadily growing, driven by rising health awareness, increasing disposable incomes and a focus on preventive healthcare. A significant development in 2023 was Abbott's launch of the new Ensure with HMB (B-Hydroxy B-Methylbutyrate), a clinically-tested nutritional supplement aimed at protecting and strengthening muscles. Nearly 40% of Indian adults suffer from muscle loss, a condition that affects overall health and mobility.

To address the issue, Ensure with HMB, fortified with 32 essential nutrients, was introduced alongside Abbott's #MusclesMatter campaign, led by cricket legend Rahul Dravid, to promote awareness about muscle health and nutritional needs. The dietary supplements segment accounts for a substantial share, with a surge in demand for vitamins, minerals, protein supplements and herbal products.

According to the Ministry of Health and Family Welfare, non-communicable diseases (NCDs), including diabetes and cardiovascular disorders, contribute to over 60% of deaths in India. These trends emphasize the need for supplements that promote overall health and address specific nutritional deficiencies.

Government initiatives, such as the Ayushman Bharat program and the National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke (NPCDCS), have amplified awareness around preventive healthcare. These programs, coupled with campaigns like #MusclesMatter, are pivotal in encouraging individuals to adopt dietary supplements as part of a healthy lifestyle. Furthermore, India's demographic shift-characterized by an aging population and urbanization-has increased the demand for supplements that support bone density, muscle strength and immunity.

Consumer Analysis

The Indian nutraceuticals market is experiencing robust growth, driven by increased health awareness, rising disposable incomes and a shift towards preventive healthcare.The primary consumers of nutraceuticals are individuals aged 25 to 45, including millennials and Generation X, who are increasingly prioritizing health and wellness. While higher-income groups have historically led the market, the growth in disposable income is now expanding the adoption of nutraceutical products across middle-income segments.

Dietary supplements, particularly vitamins and minerals, make up a large share of the market. Vitamin C, D and B-complex supplements are in high demand and the market for vitamins is expected to grow at a CAGR of 13.5% from 2025 to 2030. Functional foods and beverages are also rising in popularity, as consumers seek products that offer health benefits beyond basic nutrition. The rise of herbal supplements, leveraging Ayurvedic ingredients like ashwagandha and turmeric, further supports market growth.

E-commerce platforms are becoming increasingly important, contributing to a growing share of the market. However, challenges such as regulatory complexities and the need for consumer education, especially in rural areas, remain. Despite these hurdles, the market is poised for sustained growth with continued focus on health-conscious consumption.

Key Developments

  • In June 2024, to improve the quality of life for cancer patients receiving radiation therapy, the Department of Atomic Energy, in partnership with M/s. IDRS Labs Pvt. Ltd. Bengaluru, has launched the food supplement/nutritraceutical AKTOCYTE.
  • In August 2024, India has witnessed the launch of Aurelle Health, a direct-to-consumer nutraceutical brand that prioritizes women's hormonal health. The brand's origins can be traced back to Balaxi Pharmaceuticals and it was founded on the fact that one in five Indian women experience hormonal problems such as PCOS. The company also wants to inform women on the health of their hormones.

Competitive Landscape

The major players in the market include Amway Corporation, Herbalife Nutrition India Pvt. Ltd., Dabur India Ltd., Himalaya Wellness Company, Zydus Wellness Ltd., Nestle S.A., Glenmark Pharmaceuticals Ltd., Abbott Laboratories, Patanjali Ayurved Ltd. and Bayer Zydus Pharma Pvt. Ltd.

Why Purchase the Report?

  • To visualize the India nutraceuticals market segmentation based on type, source, form, application, end user, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of India nutraceuticals market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The India nutraceuticals market report would provide approximately 45 tables, 43 figures and 209 Pages.

Target Audience 2024

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies
Product Code: FB9079

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Type
  • 3.2. Snippet by Source
  • 3.3. Snippet by Form
  • 3.4. Snippet by Application
  • 3.5. Snippet by End User

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Growing Prevalence of Chronic Diseases
      • 4.1.1.2. Increasing Disposable Income and Urbanization
    • 4.1.2. Restraints
      • 4.1.2.1. Lack of Consumer Awareness in Rural Areas
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Russia-Ukraine War Impact Analysis
  • 5.6. DMI Opinion

6. By Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 6.1.2. Market Attractiveness Index, By Type
  • 6.2. Functional Food and Beverages*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 6.2.3. Functional Food
    • 6.2.4. Functional Beverages
  • 6.3. Dietary Supplements
    • 6.3.1. Vitamins & Mineral supplements
    • 6.3.2. Protein Supplements
    • 6.3.3. Herbal Supplements
    • 6.3.4. Plant-Based Polysaccharides
    • 6.3.5. Others

7. By Form

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 7.1.2. Market Attractiveness Index, By Form
  • 7.2. Capsules & Tablets*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Powder
  • 7.4. Liquid
  • 7.5. Chewables and Gummies

8. By Source

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 8.1.2. Market Attractiveness Index, By Source
  • 8.2. Animal Based*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Plant Based
  • 8.4. Microbial Based

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Immune Health*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Digestive Health
  • 9.4. Energy and Vitality
  • 9.5. Cognitive Function
  • 9.6. Skin and Hair Health
  • 9.7. Joint and Bone Health
  • 9.8. General Wellness
  • 9.9. Others

10. By End User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.1.2. Market Attractiveness Index, By End User
  • 10.2. Adults*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Children
  • 10.4. Elderly
  • 10.5. Athletes and Fitness Enthusiasts

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Amway Corporation *
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Herbalife Nutrition India Pvt. Ltd.
  • 12.3. Dabur India Ltd.
  • 12.4. Himalaya Wellness Company
  • 12.5. Zydus Wellness Ltd.
  • 12.6. Nestle S.A.
  • 12.7. Glenmark Pharmaceuticals Ltd.
  • 12.8. Abbott Laboratories
  • 12.9. Patanjali Ayurved Ltd.
  • 12.10. Bayer Zydus Pharma Pvt. Ltd.

LIST NOT EXHAIndiaTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!